The bill H. 3092 aims to amend the South Carolina Code of Laws by adding Section 44-41-95, which mandates the disclosure of specific medical information to women receiving a chemically induced abortion, particularly when mifepristone is administered. The bill requires that a disclosure statement be provided to the pregnant woman, informing her that mifepristone may not always be effective in terminating a pregnancy and advising her to consult a healthcare provider if she regrets her decision. The disclosure can be delivered in various ways, such as being attached to the medication package or prescription.

Additionally, the bill clarifies that it does not create or recognize a right to abortion, nor does it require the disclosure statement to be given to women experiencing a spontaneous miscarriage. It also specifies that only the facility administering the abortion is responsible for providing the disclosure, not pharmacies or other entities. The act will take effect upon approval by the Governor, and it includes a provision ensuring that if any part of the act is deemed unconstitutional, the remaining sections will still remain valid.

Statutes affected:
12/05/2024: 44-41-95
Latest Version: 44-41-95
12/06/2024: 44-41-95